Listen To The Experts

The theme of this third edition is “Enhancing Predictivity in Medicines Development,” and will be an opportunity to hear from leading academic and industry-based speakers from around the globe, as well as leading lights in the regulatory and policy-making fields

Keynote speakers

Jacques Richard

Scientific Coordinator IMI Translational Safety Strategic Governing Group

Sanofi

More info

Clayton Heijman

Director

Privium Fund Management

More info

Christopher P. Austin

Director

National Institutes of Health National Center for Advancing Translational Sciences

USA

More info

Per Arvidsson

Executive Director Drug Discovery & Development

SciLifeLab at Karolinska Institut

Sweden

More info

Irene Norstedt

Head of Unit - Innovative and Personalised Medicine

European Commission

More info

Ragnhild Løberg

Senior Vice President, Quality & Regulatory Affairs

Bayer-Algeta

More info

Isabelle Moulon

Senior Advisor on Stakeholders Engagement

European Medicines Agency

More info

Philip Murphy

Head Experimental Medicine Imaging

GlaxoSmithKline

United Kingdom

More info

Mark Schmidt

Senior Director

Janssen Research & Development

Belgium

More info

Abstracts speakers